Evidence-Based Treatment of Pseudomonas aeruginosa Infections: A Critical Reappraisal

Multidrug-resistant (MDR)/extensively drug-resistant (XDR) Pseudomonas aeruginosa is emerging as a major threat related to adverse patient outcomes. The goal of this review is to describe evidence-based empiric and targeted treatment regimens that can be exploited when dealing with suspected or conf...

Descripción completa

Detalles Bibliográficos
Autores principales: Karruli, Arta, Catalini, Christian, D’Amore, Chiara, Foglia, Francesco, Mari, Fabio, Harxhi, Arjan, Galdiero, Massimiliano, Durante-Mangoni, Emanuele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952410/
https://www.ncbi.nlm.nih.gov/pubmed/36830309
http://dx.doi.org/10.3390/antibiotics12020399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952410/
https://www.ncbi.nlm.nih.gov/pubmed/36830309
http://dx.doi.org/10.3390/antibiotics12020399

Ejemplares similares